Understanding how calcium-dependent proteins are made in the brain
Official title: Identifying the Mechanisms and Localization of Activity-Dependent CaMKII Synthesis
Funded at Brandeis University · NIH-10888186 · Data updated 2026-11-12
This study is looking at how a special protein important for communication between nerve and muscle cells is made in fruit flies, which could help us understand similar processes in human brain disorders like Alzheimer's disease.
Quick facts
| Grant type | Fellowship grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Brandeis University NIH-funded |
| Lab location | 1 site (Waltham, United States) |
| Project start | July 16, 2023 |
| Project end | July 15, 2026 |
| Funding year | 2024 |
| Award (this year) | $38,233 |
| NIH project number | 5F31NS134189-02 |
| Project ID | NIH-10888186 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for benefiting from this research are individuals affected by Alzheimer's disease or related neurodegenerative conditions.
✕Less likely to help
Patients with non-neurodegenerative conditions or those under 21 years old may not receive direct benefits from this research.
What this research studies
This research investigates the mechanisms behind the synthesis of calcium/calmodulin-dependent protein kinase II (CaMKII) at the neuromuscular junction in fruit flies. By using advanced genetic tools, the study aims to differentiate between the roles of presynaptic and postsynaptic cells in the production of CaMKII, which is crucial for synaptic plasticity. The researchers will employ GFP reporter constructs to identify specific sequences in the CaMKII gene that regulate its synthesis in response to stimulation. This approach could provide insights into how similar processes might occur in human brain disorders, particularly in conditions like Alzheimer's disease.
Why it matters
Potential benefit: If successful, this research could enhance our understanding of synaptic function and lead to new therapeutic strategies for neurodegenerative diseases.
How similar studies have gone: While this research utilizes established genetic tools in a model organism, the specific focus on CaMKII synthesis mechanisms is relatively novel and has not been extensively tested in similar studies.
Where this research is happening
-
Brandeis University
Waltham, United States Active
Researchers
- Principal investigator: Clements, Kelsey — Brandeis University
- Study coordinator: Clements, Kelsey
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.